ONT - Ticker AI Digest

Oxford Nanopore Technologies Ltd 📰 1
TradingFloor AI GO VIP Login

Digested News

Today's Catalysts (ONT) 1
ONT 14:01
Oxford Nanopore Technologies Ltd
Issue of Equity and Total Voting Rights
AI 0
No items for this category on selected date.
Acquisitions 0
No items for this category on selected date.
Agreement 0
No items for this category on selected date.
Approvals 0
No items for this category on selected date.
Authorisation 0
No items for this category on selected date.
Awards 0
No items for this category on selected date.
BTC 0
No items for this category on selected date.
Blockchain 0
No items for this category on selected date.
Breakthrough 0
No items for this category on selected date.
BuyBack 0
No items for this category on selected date.
Cancellations 0
No items for this category on selected date.
CashOffer 0
No items for this category on selected date.
Collaborate 0
No items for this category on selected date.
ContractWin 0
No items for this category on selected date.
Covid-19 0
No items for this category on selected date.
Deals 0
No items for this category on selected date.
Diamond 0
No items for this category on selected date.
DirectorDealing 1
ONT 15:01
Oxford Nanopore Technologies Ltd
Share Incentive Plan - Director/PDMR Shareholding
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
Under the SIP, the SIP Trustee will award each participating employee one Matching Share (as defined in the SIP) for each Ordinary Share <mark style="background-color:yellow">purchase</mark>d by the employee under the SIP. On 14 January 2026, the Company issued 100 Ordinary Shares to the SIP Trustee to hold on behalf of Nick Keher to satisfy the Matching Shares awarded under the SIP to him on that date.
Discovery 0
No items for this category on selected date.
Exceeded 0
No items for this category on selected date.
FCA 0
No items for this category on selected date.
FDA 0
No items for this category on selected date.
Grants 0
No items for this category on selected date.
InvestmentPlan 0
No items for this category on selected date.
JV 0
No items for this category on selected date.
Launch 0
No items for this category on selected date.
Litigation 0
No items for this category on selected date.
NewContract 0
No items for this category on selected date.
Offers 0
No items for this category on selected date.
Offtake 0
No items for this category on selected date.
Orders 0
No items for this category on selected date.
Partner 0
No items for this category on selected date.
Patents 0
No items for this category on selected date.
Placing 0
No items for this category on selected date.
Positive 0
No items for this category on selected date.
Proposals 0
No items for this category on selected date.
Reports 0
No items for this category on selected date.
Results 0
No items for this category on selected date.
Significant 0
No items for this category on selected date.
Speculation 0
No items for this category on selected date.
Strategic 0
No items for this category on selected date.
Suspension 0
No items for this category on selected date.
TR1 0
No items for this category on selected date.
Takeover 0
No items for this category on selected date.
Understanding 0
No items for this category on selected date.
Updates 1
ONT 06:01
Oxford Nanopore Technologies Ltd
Full Year Trading Update and Notice of Results
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary**
Oxford Nanopore Technologies plc released a full-year trading update for 2025, reporting strong performance with revenue growth slightly ahead of guidance. The company expects revenue of approximately £223-£224 million, representing a 22% increase on a reported basis and 24% at constant currency, exceeding its 20-23% guidance range. Growth was broad-based across all geographies (EMEAI, APAC, AMR), customer end markets (Clinical, BioPharma, Applied Industrial, Research), and product categories, led by the PromethION range. Clinical revenue grew by ~60%, BioPharma by ~30%, Applied Industrial by ~27%, and Research by ~15% despite funding pressures.
The company ended 2025 with approximately £302 million in cash and liquid investments, ahead of consensus expectations, supported by improved working capital. Oxford Nanopore remains well-capitalized to execute its strategy and continue its path to profitability. The preliminary annual results for 2025 will be announced on March 2, 2026, followed by a virtual presentation and Q&A session. The update highlights the companys progress in delivering accessible, scalable DNA and RNA analysis technology, with applications across healthcare, food, agriculture, and more.
**Key Highlights**
Revenue£223-£224 million (22% reported, 24% constant currency growth)
Broad-based growth across regionsmarketsand products
Strong cash position£302 million
Preliminary results announcementMarch 2, 2026
Vaccine 0
No items for this category on selected date.
Wins 0
No items for this category on selected date.
Worth 0
No items for this category on selected date.
All Market News (Last 30 Days) 4
ONT 14:01
Oxford Nanopore Technologies Ltd
Issue of Equity and Total Voting Rights
ONT 15:01
Oxford Nanopore Technologies Ltd
Share Incentive Plan - Director/PDMR Shareholding
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
Under the SIP, the SIP Trustee will award each participating employee one Matching Share (as defined in the SIP) for each Ordinary Share <mark style="background-color:yellow">purchase</mark>d by the employee under the SIP. On 14 January 2026, the Company issued 100 Ordinary Shares to the SIP Trustee to hold on behalf of Nick Keher to satisfy the Matching Shares awarded under the SIP to him on that date.
ONT 06:01
Oxford Nanopore Technologies Ltd
Full Year Trading Update and Notice of Results
Open AI Digest
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary**
Oxford Nanopore Technologies plc released a full-year trading update for 2025, reporting strong performance with revenue growth slightly ahead of guidance. The company expects revenue of approximately £223-£224 million, representing a 22% increase on a reported basis and 24% at constant currency, exceeding its 20-23% guidance range. Growth was broad-based across all geographies (EMEAI, APAC, AMR), customer end markets (Clinical, BioPharma, Applied Industrial, Research), and product categories, led by the PromethION range. Clinical revenue grew by ~60%, BioPharma by ~30%, Applied Industrial by ~27%, and Research by ~15% despite funding pressures.
The company ended 2025 with approximately £302 million in cash and liquid investments, ahead of consensus expectations, supported by improved working capital. Oxford Nanopore remains well-capitalized to execute its strategy and continue its path to profitability. The preliminary annual results for 2025 will be announced on March 2, 2026, followed by a virtual presentation and Q&A session. The update highlights the companys progress in delivering accessible, scalable DNA and RNA analysis technology, with applications across healthcare, food, agriculture, and more.
**Key Highlights**
Revenue£223-£224 million (22% reported, 24% constant currency growth)
Broad-based growth across regionsmarketsand products
Strong cash position£302 million
Preliminary results announcementMarch 2, 2026
ONT 06:01
Oxford Nanopore Technologies Ltd
Upcoming Investor Events and Conferences

AI Crunch

Single-Ticker AI Crunch
ONT signal theatre built from scored market catalysts, automated AI forecasts, and live trigger logic.

This is the ticker-specific AI Crunch desk for Oxford Nanopore Technologies Ltd. It compresses bullish and bearish catalyst scoring, best and worst AI forecast paths, and automated buy or sell trigger logic into one cockpit so users can judge conviction without hopping across screens.

Subscription Required Bullish vs Bearish Scoring AI Forecast Stack Buy / Sell Trigger Engine Catalyst Ledger
Create Account Member Login
Subscriber Unlock
Subscribe to unlock the full ONT AI Crunch cockpit.

Subscription turns this tab into a live signal desk with bullish vs bearish machine scoring, AI forecast stack comparisons, buy and sell trigger logic, and the full catalyst ledger behind every scored catalyst row.

  • AI-scored market headlines with sentiment buckets and buzzword breakdowns.
  • Forecast leaders ranked by projected gain against current market price.
  • Advanced technical scans, AI forecast stacks, and predictive MACD inside the live stock terminal charts.
  • Single-ticker AI Crunch desks with buy or sell trigger logic and full catalyst ledgers.
  • Scored earnings shock board with predicted direction, sector pulse and catalyst narrative.
  • Fast market scan built for event-driven trading, not passive dashboards.
Subscribe to unlock the ticker-specific signal stack, sentiment gauges, forecast stage, and the full catalyst ledger for ONT on 2026-02-02.

Fundamentals Matrix

Overall Fundamentals
Signal: Pending
Capital Strength
Signal: Pending
Float Liquidity
Signal: Pending
Short Pressure
Signal: Pending
Target Setup
Signal: Pending
Market Profile
Signal: Pending
Market Cap
1062359872
Enterprise Value
1544618437
Public Float
41.49
Broker Target
199.167
Shares Out
967364692
Long Interest
82
Short Interest
18
Exchange
LSE
Currency Code
GBX
ISIN
GB00BP6S8Z30
Market
None
Sector
Personal Care, Drug and Grocery Stores
Float / Shares Ratio
-
Short vs Long Delta
-
EV / Market Cap
-

Financials Matrix

Overall Stability
Signal: Pending
Profitability
Signal: Pending
Debt & Cash
Signal: Pending
Valuation Risk
Signal: Pending
Forward Expectation
Signal: Pending
Dividend Safety
Signal: Pending
Divi Rate
-
Ex Divi
2009-01-01
Earnings Date
2026-03-02
Net Debt
-139600000.0
Cash
181100000.0
EPS
-0.15
Net Income
-145200000.0
Revenue
223900000.0
Enterprise Value
1544618437
Trailing PE
-
Forward PE
-
Price Sales TTM
4.7448
Price Book MRQ
2.2655
EV Revenue
3.7329
EV EBITDA
-8.8899

Capital Radar

Capital Regime
—
Building signal blend...
Smart Money Tilt
—
Public vs institutions
Target Conviction
—
Broker coverage pulse
Insider Pressure
—
Director + TR1 flow
Last Held Position
-
Public Hands
-
Institutions
31.9483
Institutions As Of
2025-07-29
Avg Broker Target
-
Upside Vs Price
-
Purchase Director Dealing
23
Sale Director Dealing
6
Purchase TR1
12
Sale TR1
2
Broker Coverage Rows
12
Institution Holders Tracked
3
Public Vs Institutional Ownership (3D)
Top Institution Holders (Latest Per Holder)
Director Dealing Sentiment Flow
Broker Target Bias
Signal: Pending
Capital Momentum Matrix
Broker Targets Vs Price
Aggregated Institution Weight By Holder

Short Data - Last 30 Days

Nexus Pulse Engine

Overall Buy/Sell/Hold
Signal: Pending
Technical Composite
Signal: Pending
Financial Composite
Signal: Pending
Fundamental Composite
Signal: Pending
Short Pressure
Signal: Pending
Momentum Bias
Signal: Pending

Volatility Lab

ATR(14)
Realized Vol (20d)
Volume Spike Z

AI Charts

Today's Catalysts

1 live catalyst just hit ONT.

The headlines landing in Digested News are now framed here as today's catalyst tape. Scroll the tab rail to Digested News or jump there instantly below.
Live Tape Data 2026-02-02 AI Charts Landing View
Scroll the tab rail to Digested News any time, or use the jump button to land straight on today's tape.
1 Today
Catalyst Pulse
Oxford Nanopore Technologies Ltd has fresh news flow feeding the chart narrative.
14:01 Today's Catalyst Issue of Equity and Total Voting Rights
AI Charts Studio
ONT Price History
Live structure, automated forecasts, technical overlays and catalyst beacons in one chart workspace.
30 Day View Window 30D Data 2026-02-02 Open Preview Studio Brief
Chart Intelligence Suite
Swipe the timeframe, call the overlays, and keep the AI signal stack fused into one chart cockpit.
The mobile chart console is now framed as one connected surface so forecasting, structure, catalyst beacons and chart tools all sit inside the price workspace.

Automated signalling scans momentum shifts, crossovers and volatility breaks in real time. Automated AI forecasts map best, average and worst simulation paths forward, predictive MACD extends the momentum story, and catalyst beacons pin market-moving headlines directly onto price action so users can connect news, signals and structure without leaving the chart.

Automated Signalling Automated AI Forecasts Predictive MACD Catalyst Beacons Live Price Structure
TradingFloor AI Member Login
Indicators0
Technicals0
AI Forecast -10.65%
RSI Gauge
Price Change
AI Forecast